VolitionRx

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell VolitionRx and other ETFs, options, and stocks.

About VNRX

VolitionRX Ltd. engages in the development of blood-based cancer tests to help diagnose a range of cancers. Its products include the Nucleosomics platform that identifies and measures nucleosomes in the bloodstream or other bodily fluids. 

CEO
Cameron John Reynolds
CEOCameron John Reynolds
Employees
75
Employees75
Headquarters
Henderson, Nevada
HeadquartersHenderson, Nevada
Founded
1998
Founded1998
Employees
75
Employees75

VNRX Key Statistics

Market cap
19.78M
Market cap19.78M
Price-Earnings ratio
-0.56
Price-Earnings ratio-0.56
Dividend yield
Dividend yield
Average volume
308.08K
Average volume308.08K
High today
$2.62
High today$2.62
Low today
$2.20
Low today$2.20
Open price
$2.33
Open price$2.33
Volume
220.21K
Volume220.21K
52 Week high
$18.80
52 Week high$18.80
52 Week low
$1.91
52 Week low$1.91

Stock Snapshot

The current VolitionRx(VNRX) stock price is $2.37, with a market capitalization of 19.78M. The stock trades at a price-to-earnings (P/E) ratio of -0.56.

During the trading session on 2026-05-20, VolitionRx(VNRX) shares reached a daily high of $2.62 and a low of $2.20. At a current price of $2.37, the stock is +7.7% higher than the low and still -9.6% under the high.

Trading activity shows a volume of 220.21K, compared to an average daily volume of 308.08K.

Over the past 52 weeks, VolitionRx(VNRX) stock has traded between a high of $18.80 and a low of $1.91.

Over the past 52 weeks, VolitionRx(VNRX) stock has traded between a high of $18.80 and a low of $1.91.

VNRX News

TipRanks 15h
Analyst Lifts VolitionRx Price Target to $24 on Under-Recognized Nu.Q Platform and Expanding Clinical Applications - TipRanks

...

Analyst Lifts VolitionRx Price Target to $24 on Under-Recognized Nu.Q Platform and Expanding Clinical Applications - TipRanks
TipRanks 4d
VolitionRX Earnings Call: Breakthrough Science, Cash Burn Risk

VolitionRX Ltd. ((VNRX)) has held its Q1 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks Unlock hedge fund-level data and pow...

TipRanks 4d
VolitionRx Announces Board Streamlining as Director Departs

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

More VNRX News

TipRanks 5d
VolitionRx reports Q1 revenue $1M, consensus $409,920

Cameron Reynolds, President and Group Chief Executive Officer, said: “We have made strong progress across all of our product pillars during the first quarter an...

People also own

Based on the portfolios of people who own VNRX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.